Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1466538/000146653818000018/a10k12312017.htm
April 2022
April 2022
February 2022
February 2022
January 2022
January 2022
December 2021
December 2021
November 2021
October 2021
• | Investment banking revenue of $223.6 million on a GAAP and economic income basis in 2017, increased 68% year over year and was led by strong performance in equity financings. In addition, we made important strides towards improving revenue diversification in both product and sector. Advisory revenue of $41.8 million represented a 56% year over year increase. |
• | Annual brokerage revenue of $293.6 million and $312.8 million on a GAAP and economic income basis, respectively, represented a three-fold increase since 2012. |
• | In November 2017 the investment management division successfully launched a private healthcare strategy, an internally developed capability that leverages Cowen's longstanding strength in healthcare. |
• | As of January 1, 2018, assets under management were $11.0 billion. The $0.5 billion increase from January 1, 2017 was primarily due to subscriptions in private funds and real estate. |
• | On an economic income basis, the compensation to revenue ratio declined to 58% from 64% due to a shift in business mix as a result of the Convergex acquisition. |
• | Book value per share was $21.82 as of December 31, 2017, compared to $25.11 as of December 31, 2016. Tangible book value per share was $18.77 as of December 31, 2017 compared to $21.88 as of December 31, 2016. The per share decline is primarily due to a reduction in the value of our net deferred tax assets and shares issued in conjunction with the Convergex acquisition. |
• | In December 2017, the Company completed a full repurchase of its 8.25% senior notes due 2021 and repurchased a significant portion of its 3% convertible senior notes due 2019 and replaced them with 7.35% senior notes due 2027 and 3% convertible senior notes due 2022. |
• | On February 13th Cowen's Board of Directors approved a $23.6 million increase in the Company's share repurchase program. With this increase, the total amount available for repurchase under the program is $25.0 million. |
(Dollar amounts in millions, except per share information) | Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||||||
Dec. 31, | Sept. 30, | Dec. 31, | ||||||||||||||||||||||||||
2017 | 2016 | % | 2017 | % | 2017 | 2016 | % | |||||||||||||||||||||
GAAP: | ||||||||||||||||||||||||||||
Revenue | $ | 204.5 | $ | 122.3 | 67 | % | $ | 178.8 | 14 | % | $ | 658.8 | $ | 471.6 | 40 | % | ||||||||||||
Net income (loss) attributable to Cowen common stockholders | $ | (77.7 | ) | $ | (3.6 | ) | NM | $ | 3.0 | NM | $ | (67.7 | ) | $ | (26.1 | ) | NM | |||||||||||
Earnings (loss) per share (diluted) | $ | (2.51 | ) | $ | (0.13 | ) | NM | $ | 0.09 | NM | $ | (2.29 | ) | $ | (0.97 | ) | NM | |||||||||||
Economic Income (non-GAAP): | ||||||||||||||||||||||||||||
Economic income revenue | $ | 183.0 | $ | 128.1 | 43 | % | $ | 182.6 | — | % | $ | 666.2 | $ | 467.6 | 42 | % | ||||||||||||
Economic income (loss) attributable to Cowen | $ | (9.4 | ) | $ | (12.9 | ) | (27 | )% | $ | 8.3 | NM | $ | 15.8 | $ | (28.7 | ) | NM | |||||||||||
Economic income per share (diluted) | $ | (0.30 | ) | $ | (0.48 | ) | NM | $ | 0.26 | NM | $ | 0.54 | $ | (1.07 | ) | NM | ||||||||||||
Note: Amounts may not add due to rounding. NM indicates not meaningful. A reconciliation of economic income (loss) to net income appears under the section, "Summary Economic Income (Loss) to GAAP Reconciliation." |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1466538/000146653818000018/a10k12312017.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Cowen Inc..
Cowen Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Cowen Inc. provided additional information to their SEC Filing as exhibits
Ticker: COWN
CIK: 1466538
Form Type: 10-K Annual Report
Accession Number: 0001466538-18-000018
Submitted to the SEC: Tue Mar 06 2018 5:29:41 PM EST
Accepted by the SEC: Tue Mar 06 2018
Period: Sunday, December 31, 2017
Industry: Security Brokers Dealers And Flotation Companies